Early Access — free while we kick the tires
EdgarHawk

Wizenberg Gaelle Sandra

Director

Director
2 filings analyzed · 1 company · Latest 2024-09-13

Companies

Company Buys Sells Direction
XWELL, Inc. XWEL 3 0 Net buying

Activity

September 2024
2024-09-13 XWELL, Inc. XWEL
medium
Buy
1,201 shares
$1,987
Significance 5/10

Director Wizenberg buys 1,201 shares at $1.65, tripling holdings to 1.5K amid -46.2% annual revenue decline and $-2.0M net loss.

Wizenberg Gaelle Sandra, a director, purchased 1,201 shares at $1.65 on 2024-09-11, increasing her holdings by 401.7% from 299 to 1,500 shares. The transaction occurred as XWEL's stock trades 55.6% below its 52-week high and has declined 36.1% over the past 90 days. Notably, Wizenberg's prior two purchases at XWEL (May and April 2024) both showed positive 90-day returns, suggesting a pattern of well-timed entries at this ticker. However, this transaction's relevance is tempered by stark fundamental headwinds: the company reported annual revenue decline of -46.2% and posted a net loss of $-2.0M on quarterly revenue of only $9.3M, indicating severe operational distress. The magnitude of this buy—tripling her position in a materially declining business—presents a mixed signal between prior trading success at this ticker and deteriorating financial performance.

July 2024
2024-07-22 XWELL, Inc. XWEL
high
Buy
299 shares
$551
Significance 5/10

Director Wizenberg buys 299 shares across 2 transactions for $551.15 (blended average $1.84) at XWEL amid -46.2% revenue decline and ongoing losses

Gaelle Sandra Wizenberg, a Director at XWELL, made 2 separate purchases totaling 299 shares for $551.15 between April and May 2024 at a blended average price of $1.84, establishing an initial position from zero shares. The company is facing material headwinds: revenue declined 46.2% year-over-year, the most recent quarter shows a net loss of $2.5M on $8.7M revenue, and the company has been unprofitable over its most recent full fiscal year. The current stock price of $1.73 sits 72.1% below its 52-week high of $6.20, representing a substantial valuation decline. While the insider's entry prices of $1.83 and $1.85 remain modestly above the current market level, the purchase activity occurred against a backdrop of severe operational deterioration and significant shareholder value destruction, meriting close attention to the company's path to profitability and whether this purchase reflects insider confidence or represents a limited position-building effort amid distress.

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access